Results 71 to 80 of about 3,120,056 (305)

Other title: Report from the Health Care Access Improvement Panel

, 2015
application/pdf"2004 Senate Substitute for HB 2912 and House Substitute for SB 12 established the Health Care Access Improvement Program, which uses an annual assessment on inpatient services provided by hospitals to improve and expand health care ...
Health Care Access Improvement Panel (Kan.).
core  

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Temporal trends in ophthalmic surgical demand in a universal healthcare system: an Ontario population-based study of over two decades

BMJ Open Ophthalmology, 2022
Tina Felfeli, Beate Sander, Sherif R El-Defrawy, Gener Austria, Reeza Menalo, Diana Vasiliu, Claudia Zanchetta   +6 more
doaj   +1 more source

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)

BMC Health Services Research, 2012
Background Treatment for the hepatitis C virus (HCV) may be delayed significantly in HIV/HCV co-infected patients. Our study aims at identifying the correlates of access to HCV treatment in this population.
Salmon-Ceron Dominique, Cohen Julien, Winnock Maria, Roux Perrine, Sadr Firouze, Rosenthal Eric, Martin Isabelle, Loko Marc-Arthur, Mora Marion, Sogni Philippe, Spire Bruno, Dabis François, Carrieri Maria   +12 more
doaj   +1 more source

Access to Cancer Care

The American Surgeon™
Access to cancer care is crucial for patients to receive equitable treatment and enhance survival rates. While it is well-established that regular screenings can reduce morbidity and mortality, not all patients have the same access to these services.
Jennifer J. Butler, Anita T. Johnson, Tamra S. A. McKenzie-Johnson   +2 more
openaire   +2 more sources

Office of Health Care Access [web site] [Harvested on 2007: Apr. 11]

, 2007
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed May 24, 2011).; At head of title: State of Connecticut.; Harvested from the web on 5/24/11Official website of the Connecticut Office of Health Care Access.

core  

Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory ...
Kunihiro Ishioka, Takayasu Ohtake, Kei Ohmori, Chika Shibuya, Tomoki Tsukahara, Mizuki Yamano, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Yusuke Tsukamoto, Hidekazu Moriya, Sumi Hidaka, Shuzo Kobayashi   +12 more
wiley   +1 more source

Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine

Frontiers in Drug Delivery
Introduction: Since their introduction, adjuvanted recombinant subunit vaccines against COVID-19 have played a pivotal role in protecting global populations. Optimizing the immune response’s quality, amplitude, and durability to these vaccines depends on
William R. Lykins, Jeroen Pollet, Jeroen Pollet, Jessica A. White, Brian Keegan, Brian Keegan, Leroy Versteeg, Leroy Versteeg, Ulrich Strych, Ulrich Strych, Wen-Hsiang Chen, Wen-Hsiang Chen, Raodoh Mohamath, Gabi Ramer-Denisoff, Sierra Reed, Samuel Beaver, Alana Gerhardt, Emily A. Voigt, Mark A. Tomai, Robert Sitrin, Robert K. M. Choy, Frederick J. Cassels, Peter J. Hotez, Peter J. Hotez, Peter J. Hotez, Peter J. Hotez, Maria Elena Bottazzi, Maria Elena Bottazzi, Maria Elena Bottazzi, Christopher B. Fox, Christopher B. Fox   +30 more
doaj   +1 more source

Office of Health Care Access [web site] [Harvested on 2016: sep. 26]

, 2016
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed May 24, 2011).; At head of title: State of Connecticut.; Harvested from the web on 9/26/16Official website of the Connecticut Office of Health Care Access.

core  

Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Patients requiring long‐term continuous renal replacement therapy (CRRT) generally have poor prognoses. This study evaluated whether adding continuous intravenous sodium infusion (cIVNa) is associated with improved hemodynamics and outcomes in patients undergoing long‐term CRRT for ≥ 7 days.
Akinori Yamaguchi, Atsuyoshi Mita, Kosuke Sonoda, Makoto Harada, Koji Hashimoto, Hiroshi Imamura, Yuji Kamijo   +6 more
wiley   +1 more source